Solu Therapeutics

Developer of bifunctional small-molecule therapeutics designed to eliminate disease-driving cells. The company's platform combines selective small-molecule binders with proprietary antibodies and prov...

Healthcare

Boston, MA, United States

Founded 2022

7 employees

Website

Valuation

$104M

Market implied

Share Price

N/A

Total Raised

$72M

Last Round

N/A

Investors

+10 other investors

View all 10 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Solu Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required